EXTENT OF COVID-19 VACCINE HESITANCY AMONG

PREGNANT WOMEN OF BRGY. ANISLAGAN, PLACER, SURIGAO

DEL NORTE

A Thesis Proposal Presented to

The Faculty of the College of Allied Medical Sciences

Surigao Education Center

Surigao City

In partial Fulfillment

of the Requirements for the Degree

Bachelor of Science in Midwifery

by

JENSEN C. BASILIO
NANCY O. MONDANO
HAZEL JAMAICA M. AGGARAO

February 2022
 ACKNOWLEDGMENT

The researchers would like to express their sincere gratitude to those people who

have shared their time and help for the completion of this endeavour.

First and foremost, to the Lord Almighty God, the source of knowledge and wisdom and

our greatest provider;

The researchers’ parents for their understanding, moral and financial support.

To Engr. Christopher Arguelles, the research instructor, for giving and sharing his

knowledge, expertise and valuable suggestions;

To Mrs. Naomi N. PARNADa, RM for the imparting us with her time and

knowledge.

To the researcher’s classmates, co-workers and co-health providers, friends,

siblings their ideas and encouragement thereby achieving this stage.

The assigned healthcare personnel of BHS Anislagan,Placer, Surigao del Norte, for the

accommodation and for providing the researchers the necessary materials for the study;

For all those individuals we failed to mention we are thankful for all the support

given to us research.

The Researchers

ii
 TABLE OF CONTENTS

TITLE PAGE i

ACKNOWLEDGMENT ii

CHAPTER
1 THE PROBLEM AND REVIEW OF RELATED LITERATURE

Introduction 1
Review of Related Literature 2
Conceptual Framework 7
Statement of the Problem 10
Hypothesis 11
Significance of the Study 11
Scope and Limitation 12
Definition of Terms 12

2 RESEARCH METHODOLOGY

Research Design 14
Respondents 14
Instrument 14
Ethical Considerations 15
Data Gathering Procedure 15
Data Analysis 16

REFERENCES 17

APPENDICES

A Letter of Request to the Dean 19

B Letter of Request to RHU Chief 20
C Questionnaire 21

CURRICULUM VITAE

iii
 Chapter 1

THE PROBLEM AND REVIEW OF RELATED LITERATURE

Introduction

For almost two years since its surging coronavirus disease 2019 or COVID-19 has

been categorized as a pandemic. And, shortly after the said outbreak was declared a

pandemic across the world in early 2020, the World Health Organization (WHO) began

the organization of a global campaign of prevention, early diagnosis, and medical

treatment of the disease (Cascini, Pantovic, Al-Ajlounic, Failla & Ricciardi, 2021). It was

then clear to all that the prevention, treatment, and the only ultimate key that could

completely resolve the COVID-19 pandemic is by developing a vaccine.

However, while the availability and distribution of the vaccines remains a

challenge, even in places where vaccines are made available there is vaccine hesitancy. It

is when people have the reluctance to accept a vaccine that has been proven safe and

effective and made available to them for protection against COVID-19 (Danabal,

Magesh, Saravanan & Gopichandran 2021). This scenario is happening worldwide which

has caused problems to the government in the desire to establish a herd immunity and

stop the current COVID-19 pandemic evolution. Vaccine hesitancy is a major barrier in

achieving herd immunity across different populations (Cascini et al, 2021). So, as safe

and effective vaccines are being made available, the next challenge will be dealing with

vaccine hesitancy. Vaccine hesitancy, identified as one of the ten most important current

health threats where most people refused to be vaccinated despite the availability of

vaccines.

1
 Historically, the Philippines was one of the countries with generally high vaccine

confidence rates following the dengue vaccine controversy in 2017. However, regarding

the COVID-19 vaccines, the confidence levels have dramatically dropped and have

impacted succeeding vaccination efforts (Amit, Pepito, Sumpaico-Tanchanco & Dayrit,

2021). This is also true to other cities and municipalities in the Philippines. And so, in

Brgy. Anislagan, Placer, Surigao del Norte where there are several pregnant women,

some of them have blatantly said that they are having a second thought of getting

vaccinated. In fact, many are hesitant or unwilling to get vaccinated because of the

misinformation and unsubstantiated rumors regarding COVID-19 vaccines which are

repeatedly shared on social media platforms even before the release of an effective

vaccine. What is also controversial and misleading was the false claims on the use of

mRNA genetic material in several vaccines that can alter human DNA (Mohamed,

Solehan, Mohd Rani, Ithnin & Che Isahak, 2021).

It is along this line that the researchers intend to determine the extent of COVID-

19 vaccine hesitancy among pregnant women in Brgy. Anislagan, Placer, Surigao del

orte.

2
 Review of Related Literature

This portion of the study presents the review of the literature and studies related to

determining the extent of COVID-19 vaccine hesitancy among pregnant women. The

presentation includes some articles, journals, books, and electronic materials which have

direct bearing with the present study.

Reasons for Vaccination Hesitancy

The frequency of vaccine refusal and hesitation, which is associated with many

factors, is increasing worldwide and continue to bother the government’s plan to mitigate

the cases of individuals infected by the virus. According to İkiışık, Sezerol, Taşçı and

Maral (2021), it is an important fact that the success of the vaccination program largely

depends on the public acceptance of vaccines. However, several reasons have emerged on

the rise of hesitation to vaccination. Vaccination hesitations, simply called, unwillingness

or refusal to get vaccinated are among the ten most significant global health threats. In a

study as cited by İkiışık et al. (2021), revealed that while one in two people in the

community would accept a potential COVID-19 vaccine for all family members and

themselves, close to one-fifth of the population refused the vaccine.

Safety and Side Effects. In a study of Mohamed et al. (2021), it revealed that the

rapid development of COVID-19 vaccines has reportedly raised concerns regarding the

safety and long term effects. The case is alarming even among the medical staffs and

healthcare workers (Gagneux-Brunon, Detoc, Bruel, Tardy, Rozaire, Frappe, et al.

(2021). Among the low-middle income communities or countries, the most commonly

stated reason for vaccine refusal or hesitancy is concern about safety or side effects (Solis

Arce et al. 2021). The limited information available about potential COVID-19 vaccine

safety,
3
common and transient side effects, such as fatigue, muscle pain, joint pain and headache,

and intensive media coverage of adverse effects have soothed the hesitation among the

individuals.

The same is true with what transpired in the study conducted by Amit et al. (2021)

when it revealed that perceptions on risk of getting infection with and dying from the

virus, fear of the COVID-19 vaccine side effects, and vaccines being unsafe and deadly

resulted to vaccine refusals or delays. İkiışık et al. (2021) in their study revealed that

hesitancy among individuals towards the vaccine stem from its potential side effects,

safety, how well it works, and not trusting the government. Even among those healthcare

workers, some are hesitant about the vaccines. When their willingness to be COVID-19

vaccinated serves an important role model function for the public, their vaccination

hesitancy would make them doubtful to recommend the vaccines to the general public

and ensure mass vaccinations with the available COVID-19 vaccines (İkiışık et al., 2021).

Another study conducted by Biswas, Mustapha, Khubchandani, and Price (2021)

about the comprehensive worldwide assessment of published evidence on COVID-19

vaccine hesitancy among healthcare workers found out that vaccine safety, efficacy, and

potential side effects have been the top reasons for COVID-19 vaccination hesitancy.

This has been substantiated by the study of Al-Qerem and Jarab (2021) when it revealed

that some people still have doubts about the safety and efficacy of vaccines, including the

longevity of protection against COVID-19. Besides, the rapid development of vaccines

casts doubt on safety and these concerns about vaccine safety and side effects are global,

as indicated by studies conducted in the United States (Fisher, Bloomstone, Walder,

Crawford, Fouayzi, & Mazor, 2020), in Europe, and China (Wang, et al., 2020). It

4
furthered revealed that the rationale behind these concerns is reasonable, as several

vaccine candidate trials were paused due to detected side effects. Meanwhile, Logunov, et

al. (2021) in their research found out that hesitant respondents were most concerned

about side effects and vaccine efficacy. This calls for a proactive messaging to highlight

the high efficacy rates of the COVID-19 vaccines, and communicate accurate information

about potential side effects, including the rarity of severe adverse events that may have

contributed to hesitancy through widespread media coverage.

In the Philippines, the study of Amit et al. (2021) corroborated the foreign studies

by revealing that perceptions on risk of getting infection with and dying from the virus

have been the cause of vaccine hesitation among the selected Filipinos who participated

in the study. Their fear of the COVID-19 vaccine and its effects was greater than their

fear of the virus and outcomes. This fear and their view of vaccines being unsafe and

deadly resulted to vaccine refusals or delays. According to them, the deaths observed

after administration of the vaccine are caused by the vaccine and some also believed the

circulating theory that the life span of those who are vaccinated is shortened and they

only have two to three years to live. It can be said that safety and side effects can be

connected to having insufficient knowledge about the vaccines and so, vaccination

hesitancy persist (Biswas et al., 2021).

Belief that COVID-19 does not exist. Biswas et al. (2021) underscored that one

of the reasons or barriers to COVID-19 vaccination. In other words, many have believed

that COVID-19 does not really exist and it is not a serious disease. This was corroborated

by Edwards et al. (2021) who accentuated that those with higher vaccine resistance or

hesitancy are more likely to have a set of strongly held beliefs that COVID-19 is not real

5
which resulted to a lack of trust in those responsible for health. In this connection, the

same study recommended that alternative policy measures may well be needed to achieve

sufficient vaccination coverage especially among those with strongly held beliefs that

COVID-19 never exists.

From the study of Al-Qerem and Jarab (2021) it emphasized that undesirable

attitudes especially that of forming beliefs that COVID -19 does not exist has been used

as reason for some from declining to get vaccinated. This has been the result of the spread

of false information about the disease and the inefficiency of the vaccine. For this reason,

information drive should be strengthened and developing in the people the trust in public

health is the most essential element to vaccination acceptance so as to avoid hesitancy

(Udow-Phillips & Lantz, 2020).

Vaccine Brand Hesitancy and Brand Preferences. According to Amit et al.

(2021), vaccination hesitancy can be related to vaccine brand hesitancy or delays in

getting the vaccine due to brand preferences. In the Philippines, the first administered

vaccine was Sinovac-CoronaVac, which is manufactured by a Chinese biopharmaceutical

company. This was given to health workers despite lack of published data on

effectiveness at the time and initial announcements that these were not recommended for

high-risk individuals. In addition to concerns about the effectiveness of the vaccine, the

same study revealed that participants also read and heard information on how this vaccine

was made and believed that this specific vaccine was using the same virus to ‘immunize’

an individual’s system, which may have unintended effects (Amit et al., 2021). The said

brand was not recognized by other countries, and therefore wanted and waited for other

vaccines. Meanwhile, others refused to receive mRNA vaccines due to beliefs about its

safety and effectiveness.

6
 COVID-19 Vaccine and Pregnancy. There are several reasons why pregnant

women decline from getting vaccinated of COVID-19 vaccines. One of these reasons is

that of having risk from the vaccine which may lead to stillbirth and miscarriage.

However, Poon (2022) explained that evidence based on real life population level data

and institutional data together with several case control studies from all over the world

demonstrated that the rates of stillbirth and miscarriage following vaccination against

COVID-19 are not higher than the background rates. So, it appears that there is no

increased risk of stillbirth or miscarriage following vaccination against the COVID-19.

However, some emerging evidence shows that unvaccinated pregnant women have a

sevenfold increased risk in getting the infection compared to unvaccinated pregnant

women and amongst pregnant cases with COVID-19. Additionally, Poon (2022)

explained that women with COVID-19 who are unvaccinated have a fivefold increase in

risk of perinatal deaths, and that all perinatal deaths occur in pregnant women who are

unvaccinated at the time of COVID-19 diagnosis.

Meawhile, Goncu Ayhan, Oluklu, Atalay, Menekse Beser, Tanacan . . . Sahin

(2021) stated in their study that most common refusal reasons among pregnant women

were lack of data about COVID-19 vaccine safety in pregnant populations and possibility

of harm to the fetus. The same study concluded that there was low acceptance of COVID-

19 vaccination where pregnant women are more concerned about vaccine safety. This is

supported by the result of the study of Januszek, Faryniak-Zuzak, Barnaś, Łoziński,

Góra, . . . Kluz (2021), who revealed that the more pregnant women became hesitant

about the vaccine when the importance, effectiveness and safety of COVID-19 vaccine

for pregnant women are compromised as the mentioned reasons or barriers are

irreversibly the
7
strongest factors co-existing with the acceptance of the COVID-19 vaccination in

pregnancy.

However, this result is contrasted by the study of Skjefte, Ngirbabul, Akeju,

Escudero, Hernandez-Diaz . . . Wu (2021) who reported that there was high acceptance of

vaccines and the strongest predictors of vaccine acceptance included confidence in

vaccine safety or effectiveness, worrying about COVID-19, belief in the importance of

vaccines to their own country, compliance to mask guidelines, trust of public health

agencies/health science, as well as attitudes towards routine vaccines. It furthered

revealed that vaccine acceptance was generally highest in India, the Philippines, and all

sampled countries in Latin America but lowest in Russia, the United States and Australia.

Obviously, the vaccination hesitancy would certainly increase among pregnant and

lactating women once the safety and efficacy of COVID-19 vaccines would be delayed.

Synthesis of the Review. Several articles and studies reviewed have tackled the

reasons and barriers to vaccination hesitancy by different people in the world with respect

to the vaccine made to mitigate the spread of coronavirus. Consequently, these materials

established close connection to the objectives of the present study. The reviewed

materials provided information that helped elaborate the rationale why pregnant women

have the tendency to refuse the vaccines.

Nevertheless, slight difference can be cited due to the fact that most of the articles

and studies reviewed have dealt the occurrence of vaccine hesitancy involving not solely

with pregnant women but with that of the general population. Then, there was a limited

review of materials coming from local source which impelled the researchers to conduct

the study.

8
 Conceptual Framework of the Study

This study shall be based from the concept of Amit et al. (2021) dealing with the

fact that despite the availability of vaccines, several countries are faced with various

challenges including vaccine hesitancy and anti-vaccination sentiments, limited global

supply, and vaccine deployment. These issues in vaccine uptake, together with declining

community acceptance of other public health interventions, will mean a delayed recovery

and prolonged pandemic.

Hence, the World Health Organization (WHO) in 2019 as cited by Amit et al.

(2021) identified vaccine hesitancy or the reluctance to vaccinate as one of the top ten

threats to global health despite evidence of the important role of vaccines in improving

population health outcomes. Accordingly, the researchers anchored the present study to

the social ecological model as useful framework for the study, as cited by Amit et al.

(2021). The social ecological model explains that a multiplicity of factors interacts to

influence health of individuals such as individual factors representing biological or

behavioral characteristics, interpersonal factors representing networks and social capital

operating within a defined boundary, and structural factors that include health systems

and are mediated through laws and policies.

Thus, this study is focusing on the individual tier which involves the beliefs,

attitudes, knowledge, and health literacy of the pregnant women in Brgy. Anislagan,

Placer, Surigao del Norte towards COVID-19 vaccination hesitancy. Convincingly, the

study revolves on the extent where pregnant women manifest hesitation to vaccination

based on the individual factor as to their belief relative to safety and side effects of the

vaccine, their

9
belief and attitude that COVID-19 does not exist and to their knowledge and health

literacy involving vaccine brand hesitancy and brand preferences.

Hence, Figure 1 show the relationship of the variables which make up the entire

course of the study. Box 1 contains the socio-demographic profile of the respondents as

to age, civil status, highest educational attainment, occupation and number of pregnancy.

Box 2 includes the reasons to vaccination hesitancy such as safety and side effects, belief

that COVID-19 does not exist and vaccine brand hesitancy and brand preferences. Box 3

entails the proposed intervention plan.

Extent of Vaccination
Hesitancy as to:
Socio-demographic
Profile of the  Safety and side
Respondents as to: Effects
 Belief that COVID- Proposed Intervention
 Age
19 does not exist Plan
 Civil Status
 Vaccine brand
 Highest
hesitancy and brand
Educational
preferences
Attainment
 Occupation
 Number of
Pregnancy

Figure 1. Schematic Diagram of the Study

10
 Statement of the Problem

The study determines the extent of vaccination hesitancy among the pregnant women in

Brgy. Anislagan, Placer, Surigao del Norte.

Specifically, it seeks to answer the following questions:

1. What is the socio-demographic profile of the respondents as to:

1.1 Age

1.2 Civil Status

1.3 Highest Educational Attainment

1.4 Occupation

1.5 Number of Pregnancy?

2. What is the extent of vaccination hesitancy manifested by the pregnant women as to:

2.1 safety and side effects

2.2 belief the COVID-19 does not exist

2.3 vaccine brand hesitancy and brand preferences?

3. Is there a significant difference in the extent of vaccination hesitancy manifested by

the pregnant women when they are grouped according to their socio-demographic

profile?

4. On the basis of the study results, what intervention plan may be proposed?

Hypothesis

At 0.05 level of significance, it is hypothesized that there is no significant

difference in the extent of vaccination hesitancy manifested by the pregnant women when

they are grouped according to their socio-demographic profile.

11
 Significance of the Study

Results of the study are significantly beneficial to the following:

BHS Management. The result would help the management of the mentioned BHS

in Brgy. Anislagan, Placer, Surigao del Norte in determining the extent of vaccination

hesitancy manifested by the pregnant women. By the result, the BHS will be guided on

what to do hasten and improve the vaccination drive in the locality.

Healthcare Providers. By the result of the study, the healthcare providers like

nurses, midwives, and BHWs may be cognizant with the reasons of the pregnant women

from refusing or of their hesitancy from availing the COVID-19 vaccine. By this way,

they can initiate any measure to increase acceptability level among the pregnant women

including the greater population.

Pregnant Women. From the result of the study, the pregnant women may learn

some of the facts and information regarding the usability and importance of the vaccine.

From their doubts and hesitancy, they will be guided and informed with necessary

knowledge and reliance to the effectiveness of the vaccine. Eventually, by this study the

hesitancy level would be mitigated and may turn to increasing acceptability of the said

COVID-19 vaccine.

Future Researchers. The findings of this study would serve as the basis for

further researches related to COVID-19 pandemic and the campaign for peoples’

acceptance of the vaccine program thereby stop further COVID-19 infection or virus.

Scope and Limitation of the Study

This study focuses on determining the extent of vaccination hesitancy manifested

by the pregnant women in Brgy. Anislagan, Placer, Surigao del Norte. The respondents

of
12
the study will be the selected pregnant women within the said barangay. This study will

be conducted by the researchers within in the school year 2021-2022 in the geographical

location of Brgy. Anislagan, Placer, Surigao del Norte.

Definition of Terms

Some important terms and phrases used in the study are defined to provide clearer

understanding of the study. They are as follows:

Belief that COVID-19 does not exist. This relates to the understanding and strong

conviction of the pregnant women that COVID-19 virus is not existing and only a

manipulation of the government.

Hesitancy. This refers to the willful refusal of the pregnant women from availing

or submitting themselves for vaccination out of several reasons and barriers.

Number of Pregnancy. This refers to the number of times a woman has become

pregnant.

Pregnant Women. This is a group of individual women, unwed or wedded,

teenage mothers and pregnant students in the area who are also encourage to undergo

COVID-19 vaccination.

Safety and side Effects. This pertains to the thinking or individual beliefs of the

pregnant women that the vaccine has no established safety measures or assurances and

have some side effects seriously affecting the health of the pregnant women.

Vaccine brand hesitancy and brand preferences. This has reference to the

hesitancy of the pregnant mothers from the vaccine due to the brand. It has something to

do with the corresponding effects of each virus.

13
 Chapter 2

RESEARCH METHODOLOGY

This chapter presents the research design, participants, instruments, data

gathering procedure, and data analysis.

Research Design

A quantitative research design will be used in the study. It is the process of

collecting and analyzing numerical data as regards the extent of the vaccination hesitancy

of the pregnant women in Brgy. Anislagan, Placer, Surigao del Norte.

Respondents

The research will involve all the pregnant women in Brgy. Anislagan, Placer,

Surigao del Norte regardless of their marital status. They will be chosen using the

convenient sampling method where the researchers will go directly to the concerned

pregnant women in their respective houses or offices for the administration of the

questionnaire. Respondents need not be married or a mother, for as long as one is

pregnant by the time the administration of the questionnaire shall be conducted.

Research Instrument

A researcher-made questionnaire will be used in gathering the necessary data

and information relevant to the study. Thus, the extent of the vaccination hesitancy will

be measured using a 4-point scale as follows:

Scale Parameter Qualitative Interpretation

4 3.25-4.00 Extremely High
3 2.50-3.24 High
2 1.75-2.49 Moderate
1 1.00-1.74 Low

14
 Reliability. The researcher will choose to use Cronbach’s Alpha Coefficient for

internal consistency reliability of the questionnaire being a researcher-made. After the

test for validity and reliability will be conducted, final copies will be given to the

respondents of the study.

Ethical Considerations

As to the ethics of the study, the researchers will initially ask an ethical approval

for the conduct of the study from the school authorities through the instructor. The same

thing will be done to the management of the local BHS in Brgy. Anislagan, Placer,

Surigao del Norte.

In like manner, to manifest full respect for the dignity of the respondents, the

researchers will apply confidentiality regarding their profile. The researchers will also

apply politeness in asking data from the respondents. Then, part of the ethics is the giving

of consent forms to the respondents. The consent forms will indicate that the participation

is voluntary, and no risks will be incurred if they choose to participate, and they could

withdraw at any time or could refuse to answer any of the questions.

Privacy will be preserved and the results of this study shall remain confidential.

Any form of biases after gathering the data will be avoided.

Data Gathering Procedure

The researchers will communicate with the authorities by sending email

correspondences to formally request for the permission to conduct the study to the target

population. Thus, the researchers may ask permission from the Dean duly noted by the

adviser. Then, the researchers will draft a preliminary questionnaire that will be presented

to the research instructor, the research adviser and the members of the panel for

15
correction

16
and refinement. As soon as all of these will be secured, the researchers will personally

administer the survey questionnaire to the respondents. Data collection is confidential,

and so, the researcher will make sure that respect to the answers of the participants will

be highly observed and the identities will be kept with utmost anonymity by not requiring

them to signify their names. Thus, should the study reached the finality, all data shall be

destroyed to avoid risk of harm to the respondents.

The questionnaires will be retrieved personally by the researchers as soon as the

respondents are done with answering. The gathered data will be tallied and treated with

the help of the statistician.

Data Analysis

The data that gathered from the retrieved questionnaire will be analyzed

according to the statistical tools namely:

Frequency & Percentage Count. This tool will be used to answer problem 1 on

the profile of the respondents.

Weighted Mean and Standard Deviation. This will be used to determine the

extent of vaccination hesitancy of the pregnant women regarding COVID-19 vaccine.

One Way Analysis of Variance. (ANOVA) This tool will be utilized to

determine the significant difference in the extent of vaccination hesitancy of the pregnant

women when they are grouped according to their socio-demographic profile.

17
 REFERENCES

Al-Qerem, WA. and Jarab, AS. (2021). COVID-19 vaccination acceptance and its
associated factors among a Middle Eastern population. Front. Public Health
9:632914. doi: 10.3389/fpubh.2021.632914

Amit, AM. L., Pepito, VC. F., Sumpaico-Tanchanco, L. & Dayrit, M. L. (2021). COVID-
19 vaccine brand hesitancy and other challenges to vaccination in the Philippines.
https://doi.org/10.1101/2021.10.14.21264837

Biswas, N., Mustapha, T., Khubchandani, J. & Price, J. H. (2021). The nature and extent
of COVID-19 vaccination hesitancy in healthcare workers. Journal of Community
Health (2021) 46:1244–1251 https://doi.org/10.1007/s10900-021-00984-3 1 3

Cascini, F., Pantovic, A., Al-Ajlouni, Y., Failla, G., Ricciardi, W. (2021). Attitudes,
acceptance and hesitancy among the general population worldwide to receive the
COVID-19 vaccines and their contributing factors: A systematic review.
EClinicalMedicine, 40 101113

Danabal, KGM., Magesh, SS., Saravanan, S. & Gopichndran, V. (2021). Attitude towards
COVID 19 vaccines and vaccine hesitancy in urban and rural communities in
Tamil Nadu, India – a community based survey. BMC Health Service Researches,
21(994). https://doi.org/10.1186/s12913-021-07037-4

Edwards, B., Biddle, N., Gray, M. & Sollis, K. (2021). COVID-19 vaccine hesitancy and
resistance: Correlates in a nationally representative longitudinal survey of the
Australian population. PLoS ONE 16(3): e0248892.
https://doi.org/10.1371/journal. pone.0248892

Fisher, KA., Bloomstone, SJ., Walder, J., Crawford, S., Fouayzi, H. & Mazor, KM.
(2020). Attitudes toward a potential SARS-CoV-2 vaccine: A survey of U.S.
adults. Ann Intern Med. 173:964–73. doi: 10.7326/m2 0-3569

Gagneux-Brunon, A., Detoc, M., Bruel, S., Tardy, B., Rozaire, O., Frappe P, et al.
(2021). Intention to get vaccinations against COVID-19 in French healthcare
workers during the first pandemic wave: A cross-sectional survey. J Hosp Infect.
108:168– 73. https://doi.org/10.1016/j.jhin.2020.11.020 PMID: 33259883

Goncu Ayhan, S., Oluklu, D., Atalay, A., Menekse Beser, D., Tanacan, A., Moraloglu
Tekin, O., & Sahin, D. (2021). COVID-19 vaccine acceptance in pregnant
women. International journal of gynaecology and obstetrics: the official organ of
the International Federation of Gynaecology and Obstetrics, 154(2), 291–296.
https://doi.org/10.1002/ijgo.13713

18
İkiışık, H., Sezerol, MA., Taşçı, Y. & Maral, I. (2021). COVID-19 vaccine hesitancy: A
community-based research in Turkey. Int J Clin Pract. 75:e14336.
https://doi.org/10.1111/ijcp.14336

Januszek, S. M., Faryniak-Zuzak, A., Barnaś, E., Łoziński, T., Góra, T., Siwiec, N.,
Szczerba, P., Januszek, R., & Kluz, T. (2021). The approach of pregnant women
to vaccination based on a covid-19 systematic review. Medicina (Kaunas,
Lithuania), 57(9), 977. https://doi.org/10.3390/medicina57090977

Logunov, D. Y. et al. (2021). Safety and efficacy of a rAd26 and rAd5 vector-based
heterologous prime-boost COVID-19 vaccine: an interim analysis of a
randomized controlled phase 3 trial in Russia. Lancet 397, 671–681.

Mohamed, NA., Solehan, HM., Mohd Rani, MD., Ithnin, M., Che Isahak, CI. (2021)
Knowledge, acceptance and perception on COVID-19 vaccine among
Malaysians: A web-based survey. PLoS ONE 16(8): e0256110.
https://doi.org/10.1371/ journal.pone.0256110

Poon, L. (2022). Ask the expert-COVID-19: Maternal care. International Society of

Ultrasound in Obstetrics and Gynecology (ISUOG), Retrieved from
https://www.isuog.org/clinical-resources/ask-the-expert-covid-19-maternal-
care.html

Riad, A., Jouzová, A., Üstün, B., Lagová, E., Hruban, L., Janků, P., Pokorná, A.,
Klugarová, J., Koščík, M., & Klugar, M. (2021). COVID-19 Vaccine Acceptance
of Pregnant and Lactating Women (PLW) in Czechia: An Analytical Cross-
Sectional Study. International journal of environmental research and public
health, 18(24), 13373. https://doi.org/10.3390/ijerph182413373

Schoch-Spana, M., Brunson, EK., Long, R., Ruth, A., Ravi, SJ., Trotochaud, M, et al.
(2020). The public’s role in COVID-19 vaccination: human-centered
recommendations to enhance pandemic vaccine awareness, access, and
acceptance in the United States. Vaccine (S0264-410-2). doi:
10.1016/j.vaccine.2020.10.059.

Skjefte, M., Ngirbabul, M., Akeju, O., Escudero, D., Hernandez-Diaz, S., Wyszynski, D.
F., & Wu, J. W. (2021). COVID-19 vaccine acceptance among pregnant women
and mothers of young children: results of a survey in 16 countries. European
Journal of Epidemiology, 36(2), 197–211. https://doi.org/10.1007/s10654-021-
00728-6

Solis Arce, J. S. et al. (2021). COVID-19 vaccine acceptance and hesitancy in low- and
middle-income countries. Nature Medicine 27, 1385–1394.
www.nature.com/naturemedicine
19
Udow-Phillips, M., & Lantz, P. M. (2020). Trust in public health is essential amid the
COVID-19 pandemic. Journal of Hospital Medicine, 15(7), 431–433

Wang, J., Jing, R., Lai, X., Zhang, H., Lyu, Y., Knoll, MD, et al. (2020). Acceptance of
COVID-19 Vaccination during the COVID-19 pandemic in China. Vaccines.
8:482. doi: 10.3390/VACCINES8030482

20
 Appendix A

Letter Request to Conduct Study

February 25, 2022

MRS. TERESITA P. ADOBAS, RN, MN

Dean, College of Allied Medical Sciences
Surigao Education Center
Surigao City

Dear Madam:
The undersigned researchers are currently writing an undergraduate thesis proposal
entitled: “EXTENT OF COVID-19 VACCINE HESITANCY AMONG PREGNANT
WOMEN OF BRGY. ANISLAGAN, PLACER, SURIGAO DEL NORTE”.

In this connection, the researchers would like to ask for permission from your good office
for us to be allowed to conduct the study outside the school campus. The respondents’
responses will be of great advantage for the completion of this study.
Thank you very much for giving this request your preferential attention.

Respectfully yours,
JENSEN C. BASILIO
NANCY O. MONDANO
HAZEL JAMAICA M. AGGARAO

Researchers

Noted by:

NAOMI PARNADA, RM
Adviser

21
 Appendix B

Letter Request to Conduct Study

December 25, 2022

DR. RACHELLE JEAN O. SANCHEZ- LACUROM

Municipal Health Officer
Placer, Surigao del Norte

Dear Dr.,
Greetings in the Lord!
The undersigned researchers are currently writing an undergraduate thesis proposal
entitled: “EXTENT OF COVID-19 VACCINE HESITANCY AMONG PREGNANT
WOMEN OF BRGY. ANISLAGAN, PLACER, SURIGAO DEL NORTE”.

In this connection, the researchers would like to ask for a permission to conduct the study
within your unit. The responses or data will be of great advantage for the completion of
this study.

Thank you very much for giving this request your preferential attention.

Respectfully yours,
JENSEN C. BASILIO
NANCY O. MONDANO
HAZEL JAMAICA M. AGGARAO

Researchers

Noted by:

NAOMI PARNADA, RM
Adviser

22
 Appendix C

QUESTIONNAIRE

Part I. DEMOGRAPHIC PROFILE

Direction: Please check the space that corresponds to your answer.

Gender: Female

Age 50 years old and above

40-49 years old
30-39 years old
20-29 years old
21 years old and below

Civil Status Single Separated

Married Widowed

Highest Educational Attainment

PhD Graduate
PhD Level
Masteral Graduate
Masteral Level
College Graduate
College Level
High School Graduate
High School Level
Elementary Graduate
Elementary Level

Occupation: (Please Specify):

Number of Pregnancy
1st time
2nd time
3rd time
4th time
Others, please specify

23
Part II EXTENT OF VACCINATION HESITANCY

Direction: Please indicate the extent of your vaccination hesitancy by checking the
space of the number of your choice using the following scale:

Scale Parameter Qualitative Interpretation

4 3.25-4.00 Extremely High
3 2.50-3.24 High
2 1.75-2.49 Moderate
1 1.00-1.74 Low

SAFETY AND SIDE EFFECTS 4 3 2 1

1. The vaccine is unsafe and deadly.
2. The vaccine is not effective due to the enforcement of the booster.
3. The vaccine is unsafe as some have died after the vaccination.
4. The vaccine is just a product of experiment with no valid result yet.
5. The vaccine may cause damage to ones’ health.
BELIEFS THAT COVID-19 DOES NOT EXIST 4 3 2 1
1. Hesitant because of the belief that COVID-19 is not real.
2. Hesitant because of the belief that COVID-19 is made only by human.
3. Hesitant because of the belief that COVID-19 only exist among poor.
4. Hesitant because of the belief that COVID-19 is made only by
government
5. Hesitant because of the belief that COVID-19 is made by China.
VACCINE BRAND HESITANCY OR BRAND PREFERENCE 4 3 2 1
1. Hesitant because of lack of published data on effectiveness of the brand.
2. Hesitant because of no initial warning as not fit for high-risk individuals.
3. Hesitant because of the information how the vaccine was made.
4. Hesitant because of using the same virus to immunize an individual.
5. Hesitant because the specific brand is no recognized by other countries.s.

24